Before you sell to, join or invest in Anavatos Bio Inc.
MentionFox check on Anavatos Bio Inc.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/anavatos-bio-inc-form-d-25000001
Check Anavatos Bio Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Anavatos Bio Inc.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
Anavatos Bio Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-05-09.
Anavatos Bio Inc. filed an amended Form D notice of an exempt securities offering with the SEC on May 9, 2025. The filing reports $393K sold. Its industry group is Biotechnology. It names Leah Klein (Executive Officer) (SEC Form D/A, May 9, 2025).
Is this your company?
Sell to companies like Anavatos Bio Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-09 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Anavatos Bio Inc.
Free to see. No signup.
More on the people and the money behind Anavatos Bio Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Anavatos Bio Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Anavatos Bio Inc. raises, hires or launches. No email unless you switch it on.
Watch Anavatos Bio Inc. →Get the full cited report on Anavatos Bio Inc.
What the filing shows about Anavatos Bio Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Anavatos Bio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Anavatos Bio Inc.'s address as 2314 North 46TH Street, Seattle, WA 98103.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Anavatos Bio Inc. →
Amended on 2026-07-20: the amount sold changed from $42,500 to $392,500. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Anavatos Bio Inc. is a registered filer with the SEC (CIK 2067551) and has filed since 2025-05-09. 2 filings are on record, the latest on 2026-07-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Anavatos Bio Inc.'s Form D of 2025-05-09 names Leah Klein as its officers, directors or promoters.
Its new offerings report $43K sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Proceeds are for working capital. The number above excludes use of proceeds for normal salary and bonus to executive officers.
Leah Klein is named as Executive Officer on the Form D that Anavatos Bio Inc. filed with the SEC on 9 May 2025, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2025-05-09 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Anavatos Bio Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Anavatos Bio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Anavatos Bio Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Anavatos Bio Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Anavatos Bio Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Anavatos Bio Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Seattle
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/anavatos-bio-inc-form-d-25000001